A Review on Some Biochemical markers in mMetabolic-Associated Fatty Liver Disease
Liver is a primary organ for lipid and glucose homeostasis and is the focus of cardio metabolic disease. The NAFLD definition is combines the existence of steatosis in more than 5% of hepatocytes and metabolic risk factors, particularly obesity and T2DM, and exclusion of excessive alcohol consumpt...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Thi-Qar
2023-06-01
|
| Series: | مجلة علوم ذي قار |
| Subjects: | |
| Online Access: | https://jsci.utq.edu.iq/index.php/main/article/view/1043 |
| Summary: | Liver is a primary organ for lipid and glucose homeostasis and is the focus of cardio metabolic disease. The NAFLD definition is combines the existence of steatosis in more than 5% of hepatocytes and metabolic risk factors, particularly obesity and T2DM, and exclusion of excessive alcohol consumption defined as ? 30 g per day for men and ? 20 g per day for women, or other chronic liver diseases In 2020, it was suggest that the nomenclature of nonalcoholic fatty liver disease (NAFLD) should be updated to metabolic-associated fatty liver disease (MAFLD), Also it was found the diagnosis of MAFLD should be based on the presence of metabolic dysfunction not the absence of other conditions , MAFLD can coexist with other liver diseases and A reference to alcohol should not be included in the MAFLD acronym. Biochemical parameters play a significant role in careful diagnosis and also for risk assessment and adopting treatment that improves clinical outcome. In this article, we will highlight the nomenclature and diagnosis of metabolic-associated fatty liver disease which before 2020 was called non-alcoholic fatty liver disease, and explain some of the biochemical parameters in this disease.
|
|---|---|
| ISSN: | 1991-8690 2709-0256 |